Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02338492 · ClinicalTrials.gov registry record · NA

Safety and Efficacy Study of Treatment of Pathological Fractures in Humerus

A NA study, sponsored by IlluminOss Medical.

Completed
Registry status
NA
Development phase
81
Enrollment target

NCT02338492 is a NA study that has completed, run by IlluminOss Medical. The registered enrollment target is 81 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02338492, a NA study, has completed, sponsored by IlluminOss Medical.

COMPLETED
Registry status
NA
Development phase
81 participants
Enrollment target

Study Summary

This study will collect safety and performance data of the Photodynamic Bone Stabilization System (PBSS) when used for the treatment of fractures of the humerus secondary to metastatic cancer.

Interventions

  • DEVICE Photodynamic Bone Stabilization System

Trial Details

FieldValue
Enrollment Target 81 participants
Start Date 2015-03
Est. Completion 2017-07
Phase NA

Sponsor

IlluminOss Medical

2 total trials

What the Registry Record Tells You About NCT02338492

The ClinicalTrials.gov registry entry for NCT02338492 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 81 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is IlluminOss Medical, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Photodynamic Bone Stabilization System is the first listed.

NCT02338492 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02338492 about?

NCT02338492 is a clinical study titled "Safety and Efficacy Study of Treatment of Pathological Fractures in Humerus". This study will collect safety and performance data of the Photodynamic Bone Stabilization System (PBSS) when used for the treatment of fractures of the humerus secondary to metastatic cancer.

What is the current status of trial NCT02338492?

This trial is currently completed. It is a NA study. The enrollment target is 81 participants. The study started on 2015-03. Estimated completion is 2017-07.

What interventions are being tested in trial NCT02338492?

The interventions under investigation include: Photodynamic Bone Stabilization System (DEVICE).

Who is sponsoring clinical trial NCT02338492?

This trial is sponsored by IlluminOss Medical, which has 2 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.